Molecular Pathology of Brain Tumors
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 115
Special Issue Editor
Special Issue Information
Dear Colleagues,
CNS tumors are cancers with the worst prognosis among the common cancers, and they are the most important cause of cancer death in children. Since the publication of the WHO Classification of CNS tumors (2021), the molecular pathology of brain tumors has become a critical diagnostic, prognostic, and treatment-predictive biomarker. Newer techniques, like AI or long-read sequencing, impact the way histological and molecular data are interpreted. In this Special Issue, we bring together experts on the following areas: the molecular pathology of pediatric primary CNS lymphoma, from researchers in Hong Kong; the relationship between MGMT hypermethylation and necrosis, a key histological feature of glioblastoma, from researchers in Sydney; AI and histology and molecular pathology of brain tumors, from researchers in Vancouver; and long-read sequencing to discover structural variants in pediatric brain tumors and how NTRK fusion impacts the results of the use of NTRK inhibitors in both children and adults, from researchers in Seoul.
Prof. Dr. Ho-Keung NG
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular pathology
- brain tumors
- AI
- biomarkers
- histopathology
